January 27, 2026
A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.
January 14, 2026
New research from the University of Oklahoma has found that supplementing pregnant and lactating mice with a naturally occurring compound produced by healthy gut bacteria significantly lowered rates of fatty liver disease in their offspring as they aged.
December 17, 2025
Results of a Phase III clinical trial published recently in The Lancet show that oropharyngeal cancer patients receiving proton therapy kept their cancer under control just as well as patients receiving traditional radiation therapy, or photon therapy, and that they were more likely to be alive at the five-year mark of the study and suffered fewer side effects.
